Physician profile
Paul Kim
NPI 1285853887
$398.57
in general payments reported to CMS, 2019-2025
8 companies · $40.85 in 2025
The $40.85 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2021: $93.94 · 2022: $68.73 · 2023: $37.52 · 2025: $40.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $131.48 | 2019-2021 | |
| Abbvie INC. | $128.53 | 2021-2025 | |
| Celgene Corporation | $57.87 | 2021-2022 | |
| Amgen INC. | $21.73 | 2025 | Uplizna |
| Fresenius Kabi USA, LLC | $18.21 | 2023 | |
| Baxter Healthcare | $15.60 | 2019 | |
| Ucb, INC. | $13.89 | 2019 | |
| Daiichi Sankyo INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.